← All companies

FTH

Faeth Therapeutics, Inc.

FTH Nasdaq Pharmaceutical Preparations EDGAR ↗

$27.34

-1.48 -5.14%

Key statistics

from XBRL data in SEC filings

Market cap

$706M

Revenue (TTM)

—

Net income (TTM)

-$196M

EPS (TTM)

$-141.65

P/E ratio

—

Dividend yield

—

Free cash flow

-$20.5M

Cash

$26.9M

Total assets

$189M

Gross margin

—

52-week range

$7.20 – $37.90

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Results of operations (earnings release) Aug 4, 2026 10-Q Quarter ended 2026-06-30 Aug 4, 2026 8-K Director or officer change Jul 23, 2026 8-K Entered a material agreement; Other events Jun 18, 2026 8-K Terminated a material agreement; Director or officer change; Amended charter or bylaws; Regulation FD disclosure; Other events Jun 15, 2026 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results Jun 10, 2026 10-K/A Fiscal year ended 2025-12-31 Jun 2, 2026 8-K Other events May 22, 2026 8-K Other events May 21, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Results of operations (earnings release) May 15, 2026 8-K Director or officer change Apr 16, 2026 8-K/A Apr 15, 2026 10-K Fiscal year ended 2025-12-31 Mar 30, 2026 8-K Results of operations (earnings release) Mar 30, 2026 8-K Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Director or officer change; Amended charter or bylaws; Regulation FD disclosure Feb 18, 2026 8-K Director or officer change Feb 13, 2026 8-K Director or officer change Dec 23, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Results of operations (earnings release) Nov 14, 2025 8-K Regulation FD disclosure Oct 30, 2025 8-K Regulation FD disclosure Oct 17, 2025 10-Q Quarter ended 2025-06-30 Aug 5, 2025 8-K Results of operations (earnings release) Aug 5, 2025 8-K Delisting notice or listing-rule failure Jul 9, 2025 8-K Amended charter or bylaws Jun 13, 2025 8-K Shareholder vote results May 23, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Results of operations (earnings release) May 6, 2025 10-K Fiscal year ended 2024-12-31 Mar 28, 2025 8-K Results of operations (earnings release) Mar 28, 2025 8-K Regulation FD disclosure Mar 27, 2025 8-K Delisting notice or listing-rule failure Jan 7, 2025 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Results of operations (earnings release) Nov 14, 2024 8-K Director or officer change Oct 30, 2024 8-K Director or officer change Sep 20, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 8-K Results of operations (earnings release) Aug 6, 2024 8-K Delisting notice or listing-rule failure Jul 12, 2024